Financials
- Market Capitalization 20.45 M
- Employee 6
- Founded 2009
- CEO N/A
- Website www.kalarx.com
- Headquarter Delaware, United States
- FIGI BBG001J2MVT8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4603 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 4.92 USD | -1.99% | -2.77% | -50.50% | +303.28% | 20.60 M USD | ||
| 4606 | NXTC NextCure, Inc. - Common Stock | 5.68 USD | -13.68% | +226.44% | +175.73% | -56.64% | 20.52 M USD | ||
| 4610 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.37 USD | +4.87% | -2.87% | +0.42% | +160.44% | 20.41 M USD | ||
| 4617 | LGVN Longeveron Inc. - Class A Common stock | 0.64 USD | +3.23% | -3.03% | -18.99% | +12.03% | 19.93 M USD |